172 results on '"Zecca,Chiara"'
Search Results
2. Effectiveness, Safety and Patients’ Satisfaction of Nabiximols (Sativex®) on Multiple Sclerosis Spasticity and Related Symptoms in a Swiss Multicenter Study
3. Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis
4. Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments
5. Patterns of a structural covariance network associated with Mild Behavioural Impairment in biologically defined Alzheimer’s Disease
6. Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura
7. Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia
8. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase®
9. Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz: Update
10. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS
11. Biometry extraction and probabilistic anatomical atlas of the anterior Visual Pathway using dedicated high-resolution 3-D MRI
12. Cohort analysis of novel SPAST variants in SPG4 patients and implementation of in vitro and in vivo studies to identify the pathogenic mechanism caused by splicing mutations
13. Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type
14. Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis
15. Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis
16. Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study
17. Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica
18. Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
19. Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice
20. Incidence of syndromes associated with Frontotemporal Lobar Degeneration (S19.004)
21. Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression (P5-3.016)
22. Digital health for chronic disease management: An exploratory method to investigating technology adoption potential
23. Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice
24. Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
25. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
26. Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study
27. Synthesizing cross‐design evidence and cross‐format data using network meta‐regression
28. Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study
29. Engagement in volunteering activities by persons with multiple sclerosis in Switzerland
30. Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry
31. Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
32. Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022
33. Genotype-phenotype correlation in the spectrum of frontotemporal dementia-parkinsonian syndromes and advanced diagnostic approaches
34. Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
35. Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
36. Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
37. The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
38. Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry
39. Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis
40. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
41. Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
42. Relationship between cognitive disturbances and sleep disorders in multiple sclerosis is modulated by psychiatric symptoms
43. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
44. A CLEIA Antigen Assay in Diagnosis and Follow-Up of SARS-CoV-2-Positive Subjects
45. Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
46. The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum
47. Decipher non‐canonicalSPASTsplicing mutations with the help of functional assays in patients affected by spastic paraplegia 4 ( SPG4 )
48. Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
49. Contrast enhancement sources on post-Gadolinium “black-blood” 3D T1-weighted Turbo-Spin-Echo images in patients with multiple sclerosis. (P15-4.001)
50. Spinal Cord Lesions and Brain Grey Matter Atrophy Independently Predict Clinical Worsening in Multiple Sclerosis: A 5-Year, Multicentre Study (P16-4.004)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.